1999
DOI: 10.1002/(sici)1521-3757(19990816)111:16<2446::aid-ange2446>3.0.co;2-4
|View full text |Cite
|
Sign up to set email alerts
|

Kohlenhydratmimetika: ein neuer Lösungsansatz für das Problem der kohlenhydratvermittelten biologischen Erkennung

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
24
0

Year Published

2000
2000
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(24 citation statements)
references
References 191 publications
(154 reference statements)
0
24
0
Order By: Relevance
“…Oligosaccharides offer great potential as therapeutic agents, [1,2] and much research has been directed towards the synthesis and evaluation of enzyme inhibitors both as mechanistic and structural probes and for clinical assessment. In order to utilise multiple binding sites for oligo-and polysaccharide-degrading enzymes, inhibitors must span the catalytic centre of the enzyme, avoiding enzymatic hydrolysis whilst ideally also accommodating potential substrate distortion in the À 1 site (subsite nomenclature reviewed in ref.…”
Section: Introductionmentioning
confidence: 99%
“…Oligosaccharides offer great potential as therapeutic agents, [1,2] and much research has been directed towards the synthesis and evaluation of enzyme inhibitors both as mechanistic and structural probes and for clinical assessment. In order to utilise multiple binding sites for oligo-and polysaccharide-degrading enzymes, inhibitors must span the catalytic centre of the enzyme, avoiding enzymatic hydrolysis whilst ideally also accommodating potential substrate distortion in the À 1 site (subsite nomenclature reviewed in ref.…”
Section: Introductionmentioning
confidence: 99%
“…When the geometry of crucial groups is maintained or even improved, the obtained substances do not even need to belong to the class of carbohydrates. To grant adequate heed to mimetics is probably a means to open a wide field for rational drug design, currently, for example, exploited for the influenza A/B neuraminidase and selectins (Sears and Wong, 1999;Simanek et al, 1998;von Itzstein and Thomson, 1997). As caveats to caution against prematurely advocating clinical effectiveness of anti-adhesion therapy in inflammation or of sugar-based drugs in epidemic flu, detrimental long-term effects in an animal model mimicking both acute and chronic intestinal inflammation has been reported (McCafferty et al, 1999).…”
Section: How To Define Potent Ligand Mimeticsmentioning
confidence: 99%
“…In a series of publications [16] our group reported on the syntheses of carbohydrate mimetics [711] that are based on aminopyrans, aminooxepanes or other aminopolyols. These compounds and their conjugates were prepared to be examined as selectin inhibitors.…”
Section: Introductionmentioning
confidence: 99%